Want a 632% Gain on a Single Mental Health Stock?

It’s hard to believe that we went from an all-out prohibition on psychedelics back in the 1970s to a rush to get the FDA to approve new psychedelics treatments for mental illness. But that’s exactly where we are. And no investor in his right mind would ignore this opportunity. It’s hard to believe that we went from an all-out prohibition on psychedelics back in the 1970s to a rush to get the FDA to approve new psychedelics treatments for mental illness. But that’s exactly where we are. And no investor in his right mind would ignore this opportunity. [Energy and Capital logo] Want a 632% Gain on a Single Mental Health Stock? [Jeff Siegel Photo] By [Jeff Siegel]( Written Dec 10, 2020 Last Saturday, I celebrated my 50th birthday. I started off the day with a great CrossFit workout, treated myself to a nice lunch, and then took some psychedelic mushrooms and went on a three-hour hike in the Adirondacks. The latter was my favorite part of the day. :) I don’t typically do mushrooms a lot. For me, they really are a “special occasion” kind of thing. Moreover, I don’t see mushrooms as a party drug. Instead, I treat mushrooms more like medicine: only to be taken when needed. Every year on my birthday, I get a bit emotional and sentimental. It’s not that I have a problem getting older. It’s just that on birthdays, I tend to look back on all the good times I've had and wish for them to return. Such a thing is foolish, though. You can never properly recreate your happiest memories. And if you try, it often leads to miserable failure. Then what's left is disappointment and sadness. But when I take mushrooms, all that stuff — that psychological clutter — disappears. All the mental dust and cobwebs vanish and my brain resets — kind of like when you reboot your computer, and your central processing unit just works faster and more efficiently. Now, I know some folks — because of years of propaganda and absurd myths about the dangers of entheogens — have negative opinions about psychedelics. But the fact is many psychedelic substances have been around for centuries and used commonly as legitimate medicine. Back in the 1960s, before President Nixon declared the war on drugs, a lot of very promising research on psychedelics and mental health was being conducted. Some of that research continued underground for many years, too. But these days, psychedelics are back out in the open and about to change the entire landscape of mental health. Elon Musk Drops MASSIVE Bombshell The shrewd billionaire just made a VERY strange confession about the future of his electric car empire. The secret he reveals could also mint fortunes for smart, fast-moving investors. This has nothing to do with buying shares of Tesla. [Click here]( for the stunning details. Another Crisis, Another Opportunity If you’re a regular reader of these pages, you’ve likely read my analysis on psychedelics and mental health. You’ve read about some very promising research being done at Johns Hopkins University, where depression and addiction are being treated with psychedelic mushrooms. You’ve read about how the FDA has actually been fast-tracking clinical trials where psychedelics are being used to treat PTSD, depression, anxiety, and addiction. And, of course, you’ve read about some of the public psychedelics companies we’ve already invested in, including this one, which has already delivered a gain of 632%, with another 212% expected inside the next six months. [mm1m] The bottom line is that the U.S. is dealing with a mental health crisis of epic proportions, and it’s only being exacerbated by COVID-19. Certainly, I wish harm to no one, but with this mental health crisis sinking its teeth into our nation at an alarming rate, I’d be a fool not to seek to profit from new mental health treatments the government is now pushing for. For Your Eyes Only Your internet speeds are about to get a revolutionary upgrade. And it'll pass thanks to a little tech firm that I almost guarantee you’ve never heard of. The new generation of internet is finally here, and I’ve figured out a way you can ride this wave for over 750% profits... But only if you get in right now. [Click here to see why your internet is about to get 20 times faster]( and to discover the little-known firm behind it that’s leading the charge. It’s hard to believe that we went from an all-out prohibition on psychedelics back in the 1970s to a rush to get the FDA to approve new psychedelics treatments for mental illness. But that’s exactly where we are. And no investor in his right mind would ignore this opportunity. You know, the global behavioral health market is valued at about $200 billion. And that number increases by the day. Knowing what I know about psychedelic medicines — how the FDA is now fast-tracking clinical trials of psychedelic medicines — and capital markets... Well, let’s just say I've got a lot of skin in the psychedelics game these days. As you saw in the chart I just showed you, it’s already paying off big-time. And we haven’t even begun to scratch the surface on what this industry is about to deliver for investors who have the courage to get some of this action before Wall Street comes running. In fact, in my latest [investor note](, you can see for yourself what kind of profits we’re talking about here. I guarantee it’s like nothing you’ve ever seen before. I also put together [this special report]( on psychedelics, which includes access to the names of the psychedelic stocks I’m currently most bullish on. Unless you hate money, I strongly recommend you not only [read this report right now]( but start loading up the boat. Because the quicker you get in, the more money you’re going to make. It’s just that simple. To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel --------------------------------------------------------------- Breakthrough Technology Has COVID-19 Against a Wall The technology being used above may not appear to be revolutionary, but let me assure you that it will in fact change the world. Experts are comparing it to Alan Turing’s automatic computing engine, the technology used to beat the Axis powers in WWII, which gave way to historic gains of 21,608% for a small group of companies! And now history is repeating itself... COVID-19 has ravaged the world this year, and even though vaccines are imminent, they may not be enough. This technology is capable of targeting “invisible enemies” such as COVID-19 (among others) and is being rolled out at a time when the world needs it most. Pretty soon, this “invisible enemy” detection technology will be deployed in buildings all across the world. And this company could see post-WWII-like gains. It’s already being deployed in Walmarts, Whole Foods, Tyson chicken plants, Intel offices, and many more big-name companies. This is just the beginning, and this tiny stock is trading for just around $0.20. I’ve put all of my research together in a detailed report that gives you everything you need to know about this technology and the tiny company that is benefiting from it. You must act quickly. I don’t know how much longer this stock will stay at these levels. [Click here to get all the details on this $0.20 stock.]( Browse Our Archives [Fashion Plates and Market Darlings]( [Best-Performing Metal of COVID-19 (It's Not Gold or Silver)]( [As Crude Prices Rise, These Three Companies Should Offer Fast Profits]( [Investing in Next-Generation Solar]( [The War Within OPEC]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Energy and Capital](, Copyright © 2020, [Angel Publishing LLC](. All rights reserved. 3 E Read Street, Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Energy and Capital as well as a link to www.energyandcapital.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Energy and Capital]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Angel Publishing may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.